CAR-T translational research demands precise, reproducible, and scalable flow cytometry workflows. Manual centrifugation and antibody preparation steps remain major sources of variability and cell ...
Despite their success, significant challenges remain in developing and optimizing CAR-T therapies, particularly when broadening their use to solid tumors. Download this eBook to access our latest ...
TD2 Oncology delivers fully integrated preclinical, regulatory, and clinical services for cancer drug development. In response to advances in In Vivo CAR-T engineering, TD2 Oncology launches flow ...
Flow cytometry offers practical advantages for real-time monitoring of CAR T cell expansion, persistence, and toxicity risk in aggressive large B-cell lymphoma patients. Early CAR T cell expansion is ...
Not all patients respond well to chimeric antigen receptor (CAR) T cell therapies, which reprogram a patient’s own immune cells to recognize and attack cancer. A way to optimize these treatments is to ...
CytoFLEX nano Flow Cytometer provides high sensitivity and high resolution, enabling detection and characterization of nanoparticles at least as small as 40nm (based on polystyrene beads), accurately ...
Please could you both introduce yourselves and give a brief outline of your roles at Cerba Research? ADB: My name is Ans De Beuckelaer. I have a Ph.D. in biotechnology from the University of Ghent. In ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results